1-4 of 4
Ron Geyer, PhD
Close
Sort by
Journal Articles

Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells

Catherine Hutchinson, David P. Sheridan, MD, John F. DeCoteau, MD, Ron Geyer, PhD
Journal: Blood
Blood (2012) 120 (21): 1667.
https://doi.org/10.1182/blood.V120.21.1667.1667
Published: 2012
Journal Articles

GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling.

Ron Geyer, PhD, Teodora Zlateva, PhD, Asha Lakshmikuttyamma, PhD, David P. Sheridan, MD, John F. DeCoteau, MD
Journal: Blood
Blood (2009) 114 (22): 40.
https://doi.org/10.1182/blood.V114.22.40.40
Published: 2009
Journal Articles

Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.

Asha Lakshmikuttyamma, PhD, Stuart Scott, PhD, David P. Sheridan, MD, John DeCoteau, MD, Ron Geyer, PhD
Journal: Blood
Blood (2008) 112 (11): 3357.
https://doi.org/10.1182/blood.V112.11.3357.3357
Published: 2008
Journal Articles

RIZ1 Tumor Suppressor Regulates IGF-1 Autocrine Loop To Control Cell Proliferation, Apoptosis, and Differentiation in Chronic Myeloid Leukemia Blast Crisis Cell Lines.

Naoto Takahashi, MD, PhD, Wei-Feng Dong, MD, PhD, Matthew Bainbridge, MSc, Andrea Hull, MD, Elodie Pastural, PhD, Derek Pearson, MD, David Sheridan, MD, John DeCoteau, MD, C. Ron Geyer, PhD
Journal: Blood
Blood (2005) 106 (11): 1208.
https://doi.org/10.1182/blood.V106.11.1208.1208
Published: 2005